The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia

Schizophrenia Research

Volumn 74, Issue 2-3, 2005, Pages 253-261

  Green, Michael F ^a,b   Barnes, Thomas R ^c   Danion, Jean Marie ^d   Gallhofer, Bernd ^e   Meltzer, Herbert Y ^f   Pantelis, Christos ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^f VANDERBILT UNIVERSITY   (United States)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cognitive deficit; Functional outcome; Schizophrenia; Survey

Indexed keywords

NEUROLEPTIC AGENT;

COGNITION; COGNITIVE DEFECT; EDUCATION PROGRAM; HEALTH SURVEY; HUMAN; INTERVIEW; MEDICAL EDUCATION; PATIENT CARE; POSTAL MAIL; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSOCIAL CARE; QUESTIONNAIRE; REVIEW; SCHIZOPHRENIA; TREATMENT PLANNING;

EID: 13844272339     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.05.023     Document Type: Article

References (26)

1. D.D. Addington, J.M. Azorin, and I.R. Falloon Clinical issues related to depression in schizophrenia: an international survey of psychiatrists Acta Psychiatr. Scand. 3 2002 189 195
2. R.M. Bilder, R.S. Goldman, J. Volavka, P. Czobor, M. Hoptman, B. Sheitman, J.-P. Lindenmayer, L. Citrome, J. McEvoy, M. Kunz, M. Chakos, T.B. Cooper, T.L. Horowitz, and J.A. Lieberman Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia and schizoaffective disorder Am. J. Psychiatry 159 2002 1018 1028
3. E. Bleuler Dementia Praecox or the Group of Schizophrenias 1950 International Univ. Press New York, NY
4. C.R. Blyler, and J.M. Gold Cognitive effects of typical antipsychotic treatment: another look T. Sharma P.D. Harvey Cognition in Schizophrenia 2000 Oxford Univ. Press New York 241 265
5. G. Cassens, A.K. Inglis, P.S. Appelbaum, and T.G. Gutheil Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients Schizophr. Bull. 16 1990 477 499
6. K. Goldstein Functional disturbances in brain damage S Arieti American Textbook of Psychiatry 1959 Basic Books New York 770 794
7. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153 1996 321 330
8. M.F. Green, R.F. Kern, and D. Braff Neurocognition and functional outcomes in schizophrenia: are we measuring the right stuff? Schizophr. Bull. 26 2000 119 136
9. C. Hagger, P. Buckley, J.T. Kenny, L. Friedman, D. Ubogy, and H.Y. Meltzer Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine Biol. Psychiatry 34 1993 702 712
10. P.D. Harvey, and R.S.E. Keefe Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatments Am. J. Psychiatry 158 2001 176 184
11. P.D. Harvey, C.R. Bowie, and J.I. Friedman Cognition in schizophrenia Curr. Psychiatry Rep. 5 2001 423 428
12. R.W. Heinrichs, and K.K. Zakzanis Neurocognitive deficit in schizophrenia: a quantitative review of the evidence Neuropsychology 12 1998 426 445
13. S.E. Hyman, and W.S. Fenton Medicine. What are the right targets for psychopharmacology? Science 17 2003 350 351
14. E. Joyce, S. Hutton, S. Mutsatsa, H. Gibbins, E. Webb, S. Paul, T. Robbins, and T.R.E. Barnes Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study Br. J. Psychiatry 181 Suppl. 43 2002 38 44
15. R.S.E. Keefe, S. Perkins, S.M. Silva, and J.A. Lieberman The effect of atypical antipsychotic drugs on neurocognitive impairment of schizophrenia: a review and meta-analysis Schizophr. Bull. 25 1999 201 222
16. C. Kelly, V. Sharkey, G. Morrison, J. Allardyce, and R.G. McCreadie Nithsdale Schizophrenia Surveys: 20. Cognitive function in a catchment-area-based population of patients with schizophrenia Br. J. Psychiatry 177 2000 348 353
17. E. Kraepelin Dementia Praecox and Paraphrenia [1913/1919] 1971 Robert E. Krieger Publishing Huntingdon, NY
18. P.F. Liddle Disordered Mind and Brain: The Neural Basis of Mental Symptoms 2001 Gaskell, Royal College of Psychiatrists London
19. H.Y. Meltzer, and S.R. McGurk The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizophr. Bull. 25 1999 233 255
20. C. Pantelis, G.W. Stuart, H.E. Nelson, T.W. Robbins, and T.R.E. Barnes Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms Am. J. Psychiatry 158 2001 1276 1285
21. B.W. Palmer, R.K. Heaton, J.S. Paulsen, J. Kuck, D. Braff, M.J. Harris, S. Zisook, and D.V. Jeste Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 11 1997 437 446
22. M. Ritsner, I. Modai, J. Endicott, O. Rivkin, Y. Nechamkin, and P. Barak Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients J. Clin. Psychiatry 61 2000 880 889
23. B.R. Rund A review of longitudinal studies of cognitive functions in schizophrenic patients Schizophr. Bull. 24 1999 425 436
24. R.K. Salokangas, T. Honkonen, E. Stengard, and A.M. Koivisto To be or not to be married-that is the question of quality of life in men with schizophrenia Soc. Psychiatry Psychiatr. Epidemiol. 36 2001 381 390
25. F. Salome, F. Petitjean, C. Germain, and J.C. Demant The subjective quality of life of patients with schizophrenia: influence of psychopathology and patients' expectations. A comparative study Encephale 30 2004 60 68 (French)
26. D.B. Woodside, and E. Lin The Canadian Psychiatric Association practice profile survey. II: general description of results Can. J. Psychiatry 48 2003 244 249